Clinical Trial Update: A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement

View source ↗

Summary

This entry notes the completion of a clinical trial evaluating novel immune-modulating biomarkers in patients with axial spondyloarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Spondyloarthritis | Status: COMPLETED